Summary of Discontinued Operations |
The following tables summarizes the assets and liabilities of the discontinued operations as of September 30, 2020 and December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2020 |
|
December 31, |
|
|
(unaudited) |
|
2019 |
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Accounts receivable, net |
|
$ |
— |
|
|
$ |
497,577 |
|
Total current assets of discontinued operations |
|
$ |
— |
|
|
$ |
497,577 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
|
$ |
— |
|
|
$ |
387,975 |
|
Accrued expenses and other current liabilities |
|
5,833,729 |
|
|
3,503,037 |
|
Total current liabilities of discontinued operations |
|
5,833,729 |
|
|
3,891,012 |
|
Other long-term liabilities |
|
— |
|
|
1,755,000 |
|
Total long-term liabilities of discontinued operations |
|
$ |
— |
|
|
$ |
1,755,000 |
|
The following table summarizes the results of discontinued operations for the three and nine months ended September 30, 2020 and 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
|
(unaudited) |
|
(unaudited) |
Product revenue, net |
|
$ |
(197,505) |
|
|
$ |
3,412,044 |
|
|
$ |
(1,370,310) |
|
|
$ |
9,304,580 |
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Cost of product sales |
|
— |
|
|
1,302,679 |
|
|
— |
|
|
3,852,878 |
|
General and administrative |
|
— |
|
|
41,374 |
|
|
— |
|
|
124,121 |
|
Sales and marketing |
|
— |
|
|
2,416,338 |
|
|
— |
|
|
7,739,955 |
|
Amortization expense |
|
— |
|
|
702,665 |
|
|
— |
|
|
2,190,865 |
|
Impairment of intangible assets |
|
— |
|
|
— |
|
|
— |
|
|
1,449,121 |
|
Change in fair value of contingent consideration |
|
— |
|
|
(197,219) |
|
|
— |
|
|
247,042 |
|
Total operating expenses |
|
— |
|
|
4,265,837 |
|
|
— |
|
|
15,603,982 |
|
Other (expense) income: |
|
|
|
|
|
|
|
|
Change in value of Guarantee |
|
— |
|
|
— |
|
|
1,755,000 |
|
|
— |
|
Interest expense, net |
|
— |
|
|
(238,158) |
|
|
— |
|
|
(714,473) |
|
Total other (expense) income |
|
— |
|
|
(238,158) |
|
|
1,755,000 |
|
|
(714,473) |
|
(Loss) income from discontinued operations before tax |
|
(197,505) |
|
|
(1,091,951) |
|
|
384,690 |
|
|
(7,013,875) |
|
Income tax (benefit) expense |
|
— |
|
|
(5,989) |
|
|
— |
|
|
42,668 |
|
(Loss) income from discontinued operations, net of tax |
|
$ |
(197,505) |
|
|
$ |
(1,085,962) |
|
|
$ |
384,690 |
|
|
$ |
(7,056,543) |
|
|
|
|
|
|
|
|
|
|
The significant non-cash operating items from the discontinued operations for the nine months ended September 30, 2020 and 2019 are contained below. There were no non-cash investing items from the discontinued operations for the nine months ended September 30, 2020 and 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
2020 |
|
2019 |
Operating activities |
|
|
|
|
Amortization |
|
$ |
— |
|
|
$ |
2,190,865 |
|
Impairment of intangible assets |
|
— |
|
|
1,449,121 |
|
Stock-based compensation, excluding amount included within gain on sale of Pediatric Portfolio |
|
— |
|
|
313,790 |
|
Change in fair value of contingent consideration liability |
|
— |
|
|
247,042 |
|
Change in value of Guarantee |
|
(1,755,000) |
|
|
— |
|
|